Efficacy of racemic ketamine or esketamine monotherapy for reducing suicidal ideation in uni- or bipolar depression: a systematic review and meta-analysis
- PMID: 39382685
- DOI: 10.1007/s00406-024-01920-x
Efficacy of racemic ketamine or esketamine monotherapy for reducing suicidal ideation in uni- or bipolar depression: a systematic review and meta-analysis
Abstract
The current systematic review and meta-analysis examined the effect of racemic ketamine or esketamine on suicidal ideation in individuals with uni- or bipolar depression. We searched the MEDLINE, Embase, Central, PsycINFO, and Web of Science databases to identify randomized controlled trials that examined the effect of racemic ketamine or esketamine monotherapy on suicidal ideation (SI) in individuals with uni- or bipolar depression. The two monotherapies were compared; the primary outcome was the rate of remission of SI, and the secondary outcome was the SI score. The risk ratio was used as an effect size measure for binary variables, while the standardized mean difference was used as an effect size measure for continuous variables. Our meta-analysis included 13 randomized controlled trials involving 1,1109 individuals with uni- or bipolar depression. Patients receiving racemic ketamine monotherapy had a significantly higher acute SI remission rate than those receiving placebo or midazolam (RR = 2.06, 95% CI 1.47 to 2.91, P < 0.0001). Racemic ketamine also led to significantly lower SI scores than placebo or midazolam (SMD = -0.36, 95% CI -0.71 to -0.01, P = 0.04). The evidence for the treatment of SI with esketamine was inconsistent. The pooled effect sizes for long-term anti-SI effects did not reveal significant differences between therapies. Our study indicated the efficacy of racemic ketamine monotherapy for rapidly and transiently reducing SI in individuals with uni- or bipolar depression, but the efficacy of racemic ketamine monotherapy against long-term suicidal ideation remains unclear. There is not -sufficient evidence to support the anti-suicidal effects of esketamine monotherapy.Protocol registration: Prospero registration number: CRD42023434380.
Keywords: Bipolar disorder; Esketamine; Ketamine; Major depressive disorder; Meta-analysis; Suicidal ideation; Systematic review.
© 2024. Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
Declarations. Conflict of interest: The authors declare no conflict of interest.
Similar articles
-
Ketamine and other glutamate receptor modulators for depression in bipolar disorder in adults.Cochrane Database Syst Rev. 2015 Sep 29;(9):CD011611. doi: 10.1002/14651858.CD011611.pub2. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2021 Oct 8;10:CD011611. doi: 10.1002/14651858.CD011611.pub3. PMID: 26415966 Updated.
-
Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder.Cochrane Database Syst Rev. 2021 Sep 12;9(9):CD011612. doi: 10.1002/14651858.CD011612.pub3. Cochrane Database Syst Rev. 2021. PMID: 34510411 Free PMC article.
-
Ketamine and other glutamate receptor modulators for depression in adults with bipolar disorder.Cochrane Database Syst Rev. 2021 Oct 8;10(10):CD011611. doi: 10.1002/14651858.CD011611.pub3. Cochrane Database Syst Rev. 2021. PMID: 34623633 Free PMC article.
-
Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents.Cochrane Database Syst Rev. 2014 Nov 30;2014(11):CD008324. doi: 10.1002/14651858.CD008324.pub3. Cochrane Database Syst Rev. 2014. PMID: 25433518 Free PMC article.
-
Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents.Cochrane Database Syst Rev. 2012 Nov 14;11:CD008324. doi: 10.1002/14651858.CD008324.pub2. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2014 Nov 30;(11):CD008324. doi: 10.1002/14651858.CD008324.pub3. PMID: 23152255 Updated.
References
-
- organization WH (2021) Suicide. https://www.who.int/news-room/fact-sheets/detail/ suicide
-
- Miola A, Dal Porto V, Tadmor T et al (2021) Increased c-reactive protein concentration and suicidal behavior in people with psychiatric disorders: a systematic review and meta-analysis. Acta Psychiatr Scand 144:537–552. https://doi.org/10.1111/acps.13351 - DOI - PubMed - PMC
-
- Su MH, Chen HC, Lu ML et al (2018) Risk profiles of personality traits for suicidality among mood disorder patients and community controls. Acta Psychiatr Scand 137:30–38. https://doi.org/10.1111/acps.12834 - DOI - PubMed
-
- Li X, Mu F, Liu D et al (2022) Predictors of suicidal ideation, suicide attempt and suicide death among people with major depressive disorder: a systematic review and meta-analysis of cohort studies. J Affect Disord 302:332–351. https://doi.org/10.1016/j.jad.2022.01.103 - DOI - PubMed
-
- Paljärvi T, Tiihonen J, Lähteenvuo M et al (2023) Psychotic depression and deaths due to suicide. J Affect Disord 321:28–32. https://doi.org/10.1016/j.jad.2022.10.035 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical